Literature DB >> 14657555

Anti-alpha-fodrin autoantibodies in Moyamoya disease.

Kouichi Ogawa1, Shinji Nagahiro, Rieko Arakaki, Naozumi Ishimaru, Masaru Kobayashi, Yoshio Hayashi.   

Abstract

BACKGROUND AND
PURPOSE: Moyamoya disease (MMD) is a rare entity that results in progressive occlusion of the arteries of the circle of Willis, but the pathogenesis of MMD is unknown.
METHODS: MMD sera (n=32) were tested for anti-endothelial cell antibodies by enzyme-linked immunoassays and flow cytometric analysis. Apoptosis was induced in human umbilical vein endothelial cells by tumor necrosis factor-alpha.
RESULTS: We found that a high proportion of MMD sera had anti-endothelial cell antibodies with apoptotic stimuli. Prominent reactivities of MMD sera (72%) with recombinant human alpha-fodrin were observed.
CONCLUSIONS: Our study demonstrates that MMD sera contain a high incidence of anti-alpha-fodrin autoantibodies, providing new insight into the mechanisms of occlusion of MMD arteries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657555     DOI: 10.1161/01.STR.0000100479.63243.48

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.

Authors:  Jason J DeVoss; Norbert P LeClair; Yafei Hou; Navdeep K Grewal; Kellsey P Johannes; Wen Lu; Ting Yang; Craig Meagher; Lawrence Fong; Erich C Strauss; Mark S Anderson
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

2.  Moyamoya syndrome causing stroke in young women with type 1 diabetes.

Authors:  Jing W Hughes; Jennifer A Wyckoff; Abby S Hollander; Colin P Derdeyn; Janet B McGill
Journal:  J Diabetes Complications       Date:  2016-08-12       Impact factor: 2.852

Review 3.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

4.  Immune response profiling identifies autoantibodies specific to Moyamoya patients.

Authors:  Tara K Sigdel; Lorelei D Shoemaker; Rong Chen; Li Li; Atul J Butte; Minnie M Sarwal; Gary K Steinberg
Journal:  Orphanet J Rare Dis       Date:  2013-03-21       Impact factor: 4.123

5.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

6.  A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How.

Authors:  Xiaoli Si; Lingfei Li; Yuanjian Fang; Yaping Yan; Jiali Pu
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

7.  Epigenome-Wide Association Study Reveals Differential Methylation Sites and Association of Gene Expression Regulation with Ischemic Moyamoya Disease in Adults.

Authors:  Shihao He; Xun Ye; Ran Duan; Yahui Zhao; Yanchang Wei; Yanru Wang; Ziqi Liu; Xiaokuan Hao; Xiaolin Chen; Qiang Hao; Hao Wang; Yuanli Zhao; Rong Wang
Journal:  Oxid Med Cell Longev       Date:  2022-03-24       Impact factor: 6.543

8.  Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease.

Authors:  Wenxiu Han; Feng Jin; Hailiang Zhang; Mengqi Yang; Changmeng Cui; Changshui Wang; Pei Jiang
Journal:  Mediators Inflamm       Date:  2020-04-28       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.